sanofi bid goes hostile , page-4

red It would appear that this drug is what kept them negotiating for so long
http://www.evaluatepharma.com/Universal/View.aspx?type=Story&id=237958§ionID=&isEPVantage=yes

there are some intersting marketing problems with it
http://www.bnet.com/blog/drug-business/sticker-shock-genzyme-may-want-60000-for-its-new-ms-drug/6867

At that price if anyone in my family had MS it would be tough luck
It will be interesting to see what ends up in our syringes